Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 11/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.67 |
| ▸ | RAD52 | P43351 | 2/20 | 0.67 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.61 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9893627 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL37598 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL1172468 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL149817 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL13904606 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL1049292 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL1172061 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL9577048 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL585746 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL31345291 | 1.00 | DNM1 (1.00) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3620051-B1 | CLEANING COMPOSITION INCLUDING BOTH A DISINFECTANT AND A LONG-LASTING ANTIMICROBIAL COMPONENT | Parasol Medical LLC (US) | 2025-12-03 | — | — | EP | claimed |
| CN-103254671-B | Antimicrobial coatings | 3M创新有限公司 | 2017-05-03 | — | — | CN | claimed |
| JP-8026954-A | — | — | None | — | — | JP | disclosed |
| US-20250066270-A1 | PROCESS FOR SELECTIVE ETHYLENE OLIGOMERIZATION WITH ANTIFOULING COMPONENTS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-02-27 | — | — | US | disclosed |
| US-11786889-B2 | Antifouling oligomerization catalyst systems | SAUDI ARABIAN OIL COMPANY (SA) | 2023-10-17 | — | — | US | disclosed |
| EP-4252545-A1 | METHODS AND ARTICLES FOR KEEPING FOOD FRESHER FOR LONGER AND SHELF-LIFE EXTENSION TO ENHANCE FOOD SECURITY AND SAFETY | Zoono Group Ltd. (NZ) | 2023-10-04 | — | — | EP | disclosed |
| US-20230097707-A1 | METHODS AND ARTICLES FOR KEEPING FOOD FRESHER FOR LONGER AND SHELF-LIFE EXTENSION TO ENHANCE FOOD SECURITY AND SAFETY | Zoono Group Ltd (NZ) | 2023-03-30 | — | — | US | disclosed |
| CN-114901291-A | Antibacterial organosilanes | 托皮科斯药品公司 | 2022-08-12 | — | — | CN | disclosed |
| EP-3336172-B1 | METHOD FOR PRODUCING ANTIGEN SPECIFIC MONOCLONAL ANTIBODY | NATIONAL UNIV CORPORATION UNIV OF TOYAMA (JP) | 2020-09-23 | — | — | EP | disclosed |
| US-10416165-B2 | Method for producing antigen specific monoclonal antibody | NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (JP) | 2019-09-17 | — | — | US | disclosed |
| US-20180292407-A1 | METHOD FOR PRODUCING ANTIGEN SPECIFIC MONOCLONAL ANTIBODY | NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (JP) | 2018-10-11 | — | — | US | disclosed |
| US-20120015200-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-01-19 | — | — | US | disclosed |
| WO-2011150103-A2 | ANTIMICROBIAL–COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011150001-A2 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| CN-101291743-A | Antimicrobial cationic polyelectrolyte coatings | QUICK MED TECHNOLOGIES INC UNI (US) | 2008-10-22 | — | — | CN | disclosed |
| CN-101228210-A | Method of creating a solvent-free polymeric silicon-containing quaternary ammonium antimicrobial agent having superior sustained antimicrobial properties | BIOSAFE INC (US) | 2008-07-23 | — | — | CN | disclosed |
| WO-2003082348-A1 | NANOGEL NETWORKS INCLUDING POLYION POLYMER FRAGMENTS AND BIOLOGICAL AGENT COMPOSITIONS THEREOF | SUPRATEK PHARMA INC. (CA) | 2003-10-09 | — | — | WO | disclosed |
| US-6384254-B1 | ANTIMICROBIAL; SOFTNESS; WEAR RESISTANCE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| JP-H0826954-A | ADSORPTIVE REMOVER FOR ENDOTOXIN DERIVED FROM PERIODONTOTIC BACTERIUM | SUNSTAR INC | 1996-01-30 | — | — | JP | disclosed |
| CN-1090708-A | Antibacterial agent and utilization thereof | TOKUYAMA SODA KABUSHIKIK KAISH (JP) | 1994-08-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786889-B2 | Antifouling oligomerization catalyst systems | PFAS, PUF60, AS3MT | DNM1 1453/4885HTT 2524/4885KMT2A 4169/4885 |
| US-20250066270-A1 | PROCESS FOR SELECTIVE ETHYLENE OLIGOMERIZATION WITH ANTIFOULING COMPONENTS | OR10J3, MRTO4, AS3MT | DNM1 1792/4885HTT 1454/4885KMT2A 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.